Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03105479 · ClinicalTrials.gov registry record · Phase 2
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)
A Phase 2 study, sponsored by Actelion.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT03105479 is a Phase 2 study that was terminated before completion, run by Actelion. The registered enrollment target is 1 participants.
The verdict
NCT03105479, a Phase 2 study, was terminated before completion, sponsored by Actelion.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Cadazolid has demonstrated activity against a bacteria named Clostridium difficile in animal studies. The results of a first study conducted in adult patients have suggested efficacy of the new antibiotic, cadazolid, in the treatment of diarrhea caused by this bacteria. This is the first study of cadazolid in children. The overall purpose of this study is to provide reassurance on the safety and efficacy of cadazolid in children suffering from infection due to Clostridium difficile.
Interventions
- DRUG Cadazolid
- DRUG Vancomycin capsule
- DRUG Vancomycin solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-04-14 |
| Est. Completion | 2018-04-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03105479
The ClinicalTrials.gov registry entry for NCT03105479 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Actelion, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cadazolid is the first listed.
NCT03105479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03105479 about?
NCT03105479 is a clinical study titled "Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)". Cadazolid has demonstrated activity against a bacteria named Clostridium difficile in animal studies. The results of a first study conducted in adult patients have suggested efficacy of the new antibiotic, cadazolid, in the treatment of diarrhea caused by this bacteria. This is the first study of ca...
What is the current status of trial NCT03105479?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2017-04-14. Estimated completion is 2018-04-17.
What interventions are being tested in trial NCT03105479?
The interventions under investigation include: Cadazolid (DRUG), Vancomycin capsule (DRUG), Vancomycin solution (DRUG).
Who is sponsoring clinical trial NCT03105479?
This trial is sponsored by Actelion, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.